FDA clears Novo Nordisk's weight loss drug Saxenda
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
The Food and Drug Administration has approved a Novo Nordisk diabetes drug as a treatment for obesity. It's the first injectable drug approved for weight loss.
Dec 23, 2014
Identifying brain variations may help physicians predict which patients will respond to a neurosurgical procedure to treat obsessive-compulsive disorder (OCD) that does not respond to medication or cognitive-behavioral therapies, ...
Dec 23, 2014
While indoor tanning has decreased among high school students, about 20 percent of females engaged in indoor tanning at least once during 2013 and about 10 percent of girls frequently engaged in the practice by using an indoor ...
Dec 23, 2014
Among patients in England with gout, only a minority of those with indications to receive urate-lowering therapy were treated according to guideline recommendations, according to a study in the December 24/31 issue of JAMA.
Dec 23, 2014
High-risk children with chronic illness who received care at a clinic that provided both primary and specialty care and features to promote prompt effective care had an increase in access to care and parent satisfaction and ...
Dec 23, 2014
In the largest and most comprehensive study of heat-related illness to date, Harvard School of Public Health (HSPH) researchers have identified a handful of potentially serious disorders—including fluid and electrolyte ...
Dec 23, 2014
The most popular treatment for type 2 diabetes, metformin, may be safer for patients with mild to moderate kidney disease than guidelines suggest, according to a new, systematic review of the literature published by Yale ...
Dec 23, 2014
Health authorities in the U.S. are taking fresh aim at a "silent killer" with a recommendation that all American adults be screened for high blood pressure.
Dec 23, 2014